Key Highlights
- ARK Invest purchased 83,764 CoreWeave shares valued at approximately $6.9M in the Nvidia-supported AI cloud infrastructure firm
- The investment firm established its inaugural direct stake in OpenAI, purchasing nearly 349,000 shares distributed among three funds
- Portfolio additions include Kodiak AI autonomous trucking, Oklo nuclear technology, DoorDash, plus genomics companies Arcturus and GeneDx
- Divestments featured 745K Strata Critical Medical shares alongside reductions in Teradyne, Pinterest, and Veracyte positions
- ARKK has declined approximately 12% in 2025, experiencing $1.2 billion in net withdrawals during the trailing twelve months
Cathie Wood’s investment firm executed a decisive shift toward artificial intelligence infrastructure, biotechnology, and sustainable energy sectors throughout the past week, acquiring substantial new stakes while divesting from multiple portfolio companies.
The most significant acquisition involved CoreWeave, an Nvidia-supported cloud infrastructure provider specializing in GPU-accelerated data centers for artificial intelligence applications. ARK accumulated 83,764 shares over three consecutive trading days — March 30, 31, and April 1 — representing approximately $6.9 million in value calculated at the $82 closing price.
CoreWeave, Inc. Class A Common Stock, CRWV
CoreWeave’s client roster features technology giants including Google and Microsoft. The company disclosed fourth-quarter revenue reaching $1.57 billion in February, representing 110% year-over-year expansion. However, its first-quarter forecast of $1.9 to $2 billion fell short of the $2.29 billion analyst consensus.
Bank of America elevated CoreWeave to a buy rating in March with a $100 price objective. The bank’s analysts highlighted the company’s strategic positioning within what they estimate as a $79 billion artificial intelligence infrastructure sector.
ARK also established its maiden direct investment in OpenAI, the organization responsible for ChatGPT. Three ARK portfolios — ARKF, ARKK, and ARKW — collectively acquired 348,995 shares or units via a Series C allocation. The firm characterized this as its first direct capitalization table position in OpenAI.
Autonomous Transportation and Next-Gen Nuclear Investments
ARK’s ARKQ portfolio acquired 230,000 shares of Kodiak AI, a developer specializing in autonomous trucking systems and artificial intelligence logistics solutions. The firm additionally secured approximately 56,000 shares of Oklo, an advanced nuclear energy venture pioneering next-generation fission reactor technology.
DoorDash represented another portfolio expansion, with ARK increasing its consumer technology sector exposure through the meal delivery platform.
Within the genomics sector, ARK’s ARKG fund purchased over 16,000 shares of Arcturus Therapeutics, a company developing RNA-based therapeutic solutions. The firm also accumulated 39,000 shares of GeneDx, a genetic diagnostics and precision medicine provider, distributed between ARKG and ARKK portfolios.
Portfolio Reductions: Strata, Teradyne, and Digital Platforms Scaled Back
Regarding divestments, ARK’s most substantial reduction by volume involved Strata Critical Medical. The firm liquidated 745,000 shares representing approximately $3 million in value.
ARK similarly decreased its holdings in Veracyte, a molecular diagnostics company, and reduced exposure to semiconductor testing equipment manufacturer Teradyne. Pinterest, Discovery, and Japanese digital platform LY Corp also experienced position reductions.
Wood has publicly forecasted a “great acceleration” in worldwide economic expansion fueled by artificial intelligence technologies. She projects AI training expenses are declining 75% annually while inference costs are plummeting between 85% and 98% per year.
ARKK has decreased roughly 12% year to date, contrasting with the S&P 500’s 3.8% decline. The flagship fund has registered $1.2 billion in net capital outflows throughout the past twelve months.
CoreWeave settled at $82.24 on April 2, posting a 15% year-to-date gain.





